Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Revenue

Medigen Vaccine Biologics had revenue of 205.86M TWD in the quarter ending September 30, 2025, a decrease of -15.29%. This brings the company's revenue in the last twelve months to 594.96M, down -8.21% year-over-year. In the year 2024, Medigen Vaccine Biologics had annual revenue of 605.64M with 55.44% growth.

• Revenue (ttm): 594.96M
• Revenue Growth: -8.21%
• P/S Ratio: 22.35
• Revenue / Employee: 5.78M
• Employees: 103
• Market Cap: 13.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	605.64M	216.01M	55.44%
Dec 31, 2023	389.62M	24.58M	6.73%
Dec 31, 2022	365.04M	-2.92B	-88.87%
Dec 31, 2021	3.28B	3.27B	28,413.03%
Dec 31, 2020	11.51M	10.39M	927.41%